Pronova reports strong revenue growth in 2007 Q4 and full year

Pronova BioPharma ASA, which produces marine-originated pharmaceutical products, said revenues increased by 32.3% in the fourth quarter of 2007 to NOK 269.4 million on stronger US sales of its lead product, Lovaza.